AlzChem Group AG (ETR:ACT)
Germany · Delayed Price · Currency is EUR 171.80
-2.30 (-1.32%)
Jul 28, 2026, 1:40 PM CET
AlzChem Group AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 600.25 | 601.5 | 566.22 | 550.7 | 588.59 | 443.68 | |
Revenue Growth | 3.40% | 6.23% | 2.82% | -6.44% | 32.66% | 14.52% |
Cost of Revenue | 187.2 | 198.29 | 195.66 | 225.15 | 288.88 | 170.67 |
Gross Profit | 413.05 | 403.21 | 370.55 | 325.56 | 299.72 | 273.01 |
Selling, General & Admin | 176.58 | 173.61 | 160.5 | 145.64 | 137.14 | 132.17 |
Depreciation & Amortization Expenses | 26.8 | 26.65 | 26.32 | 25.9 | 25.54 | 24.47 |
Other Operating Expenses | 115.07 | 113.12 | 104.79 | 98.55 | 101.14 | 78.8 |
Total Operating Expenses | 318.45 | 313.38 | 291.6 | 270.08 | 263.82 | 235.44 |
Operating Income | 94.61 | 89.83 | 78.95 | 55.47 | 35.9 | 37.57 |
Interest Income | 2.91 | 3.24 | 2.23 | 0.38 | 8.42 | 0.64 |
Interest Expense | -5.18 | -5.13 | -5.84 | -7.67 | -3.04 | -1.7 |
Total Non-Operating Income (Expense) | -2.27 | -1.89 | -3.61 | -7.28 | 5.38 | -1.06 |
Pretax Income | 92.33 | 87.94 | 75.34 | 48.19 | 41.28 | 36.51 |
Provision for Income Taxes | 25.34 | 24.31 | 21.1 | 13.4 | 11.06 | 8.75 |
Net Income | 67 | 63.63 | 54.25 | 34.79 | 30.22 | 27.76 |
Minority Interest in Earnings | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
Net Income to Common | 66.82 | 63.46 | 54.08 | 34.62 | 30.05 | 27.59 |
Net Income Growth | 18.33% | 17.35% | 56.19% | 15.20% | 8.91% | 40.11% |
Shares Outstanding (Basic) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Outstanding (Diluted) | 10 | 10 | 10 | 10 | 10 | 10 |
Shares Change | -0.48% | -0.67% | 0.05% | 0.33% | -0.11% | -0.29% |
EPS (Basic) | 6.61 | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 |
EPS (Diluted) | 6.61 | 6.28 | 5.31 | 3.40 | 2.96 | 2.72 |
EPS Growth | 18.88% | 18.27% | 56.18% | 14.87% | 8.82% | 40.21% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 3.92 | 39.22 | 62.05 | 52.11 | -33.31 | 14.48 |
Free Cash Flow Growth | -94.55% | -36.78% | 19.06% | - | - | -27.15% |
Free Cash Flow Per Share | 0.39 | 3.88 | 6.10 | 5.12 | -3.29 | 1.43 |
Dividends Per Share | 2.100 | 2.100 | 1.800 | 1.200 | 1.050 | 1.000 |
Dividend Growth | 16.67% | 16.67% | 50.00% | 14.29% | 5.00% | 29.87% |
Gross Margin | 68.81% | 67.03% | 65.44% | 59.12% | 50.92% | 61.53% |
Operating Margin | 15.76% | 14.93% | 13.94% | 10.07% | 6.10% | 8.47% |
Profit Margin | 11.16% | 10.58% | 9.58% | 6.32% | 5.13% | 6.26% |
FCF Margin | 0.65% | 6.52% | 10.96% | 9.46% | -5.66% | 3.26% |
EBITDA | 121.4 | 116.48 | 105.27 | 81.37 | 61.44 | 62.05 |
EBITDA Margin | 20.23% | 19.36% | 18.59% | 14.78% | 10.44% | 13.98% |
EBIT | 94.61 | 89.83 | 78.95 | 55.47 | 35.9 | 37.57 |
EBIT Margin | 15.76% | 14.93% | 13.94% | 10.07% | 6.10% | 8.47% |
Effective Tax Rate | 27.44% | 27.64% | 28.00% | 27.80% | 26.79% | 23.96% |